BeOne Medicines AG
BEIGF
$22.50
-$1.25-5.25%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 17,802.13% | 143.79% | 202.88% | 178.34% | 100.51% |
| Total Depreciation and Amortization | 24.57% | -29.81% | -49.01% | 25.73% | 31.19% |
| Total Amortization of Deferred Charges | 48.51% | 30.60% | 29.60% | 388.45% | -0.85% |
| Total Other Non-Cash Items | 38.56% | -22.67% | 30.06% | 13.25% | 21.19% |
| Change in Net Operating Assets | -142.41% | 967.10% | -23.34% | 104.72% | 49.78% |
| Cash from Operations | 356.73% | 455.28% | 113.70% | 375.76% | 114.29% |
| Capital Expenditure | 27.69% | 59.43% | 64.02% | 60.14% | 63.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.80% | 27.73% | -424.23% | -2,005.27% | -23.06% |
| Cash from Investing | 62.68% | 59.05% | 63.20% | 40.01% | 41.89% |
| Total Debt Issued | -27.25% | 58.63% | -- | -22.40% | -47.05% |
| Total Debt Repaid | 95.69% | -40.64% | -19.71% | 31.25% | -4,849.32% |
| Issuance of Common Stock | -62.32% | 118.79% | 396.42% | 495.69% | 328.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 303.19% | 2,243.07% | 7,491.79% | 52.17% | -120.81% |
| Foreign Exchange rate Adjustments | 455.17% | 144.79% | -65.06% | 497.78% | 115.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 325.39% | 768.32% | 1,286.91% | 234.82% | 71.43% |